TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive Cancer Survival Now May Be Well Over 50 Percent, ACS President Says; Cigarette Consumption Drops April 6, 1984
TCL Archive White House Estimates Automatic Budget Cuts Would Take 8.2 Percent From NCI, NIH and FDA September 21, 2012